ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2308건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2196 | Completed | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | COVID-19 | Drug: Nafamostat Mesilate | Phase 2 | Chong Kun Dang Pharmaceutical | INDUSTRY | 13 | All | 18 Years | Korea Cancer Center Hospital, Seoul, Korea, Republic of |
| 2195 | Completed | A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 | COVID-19 | Drug: Tocilizumab | Phase 1 | Hoffmann-La Roche | INDUSTRY | 2 | All | ~ 17 Years | Reagan UCLA Medical Center, Los Angeles, California, United States The University of Chicago, Chicago, Illinois, United States Central Michigan University College of Medicine, Mount Pleasant, Michigan, United States Feinstein Institute for Medical Research, Manhasset, New York, United States University Hospitals Cleveland Medical Center, Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States UT Physicians - Pediatric Center - Texas Medical Center, Houston, Texas, United States University of Utah - PPDS, Salt Lake City, Utah, United States Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, Brazil Klinika Za Djecje Bolesti Zagreb, Zagreb, Croatia University Hospital for Infection Diseases "Dr. Fran Mihaljevic" - PPDS, Zagreb, Croatia CHRU Montpellier; SMPEA Peyre Plantade Centre de Ressources Autisme, Montpellier, France Hospital Necker, Paris, France Assistance Publique Hopitaux de Paris, Val-de-Marne, France Uniklinik Koln, Koln, Germany Universitatsklinikum Ulm, Ulm, Germany Hippokration Hospital, Thessaloniki, Greece IRCCS Ospedale Pediatrico Bambino Gesu - INCIPIT - PIN, Roma, Lazio, Italy ASST di Lecco - Presidio Ospedaliero A. Manzoni di Lecco, Lecco, Lombardia, Italy Szpital Kliniczny im Karola Jonschera Uniwersytetu Medycznego im Karola Marcinkowskiego w Poznaniu, Poznan, Poland Global Clinical Trials Sunnyside, Pretoria, South Africa Hospital Sant Joan de Deu - PIN; Unitat de Recerca - Farmacia, Esplugues de Llobregat, Barcelona, Spain Hospital Infantil Universitario Nino Jesus; Seccion de Neuropediatria, Madrid, Spain Hospital Universitario 12 De Octubre, Madrid, Spain Hospital Universitario La Paz - PPDS, Madrid, Spain Great North Childrens Hospital, Newcastle upon Tyne, United Kingdom |
| 2194 | Withdrawn | A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 | COVID-19 | Drug: MRx-4DP0004 Drug: Placebo |
Phase 2 | 4D pharma plc | INDUSTRY | 0 | All | 18 Years | University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom |
| 2193 | Completed | A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 | SARS-CoV-2 Infection | Drug: BTL-TML-COVID Drug: Placebo |
Phase 2 | Beech Tree Labs, Inc., Norwich Clinical Research Associates Ltd., Curavit Clinical Research | INDUSTRY | 28 | All | 40 Years | Intermountain Clinical Reserach, Draper, Utah, United States |
| 2192 | Unknown status | A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study | Covid-19 | Drug: Anakinra Prefilled Syringe Drug: Tocilizumab Prefilled Syringe Drug: Standard-of-care treatment |
Phase 2 | Karolinska University Hospital, Karolinska Institutet | OTHER | 120 | All | 18 Years | Karolinska University Hospital, Huddinge, Stockholm, Sweden |
| 2191 | Completed | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults | COVID-19 | Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant Other: Placebo |
Phase 2 | Novavax, Bill and Melinda Gates Foundation | INDUSTRY | 4422 | All | 18 Years ~ 84 Years | ZA018, Bloemfontein, Free State Of South Africa, South Africa ZA003, Hillbrow, Gauteng, South Africa Site ZA001, Johannesburg, Gauteng, South Africa ZA012, Johannesburg, Gauteng, South Africa Site ZA015, Pretoria, Gauteng, South Africa ZA023, Pretoria, Gauteng, South Africa ZA019, Durban, KwaZulu-Natal, South Africa ZA020, Durban, KwaZulu-Natal, South Africa ZA021, Durban, KwaZulu-Natal, South Africa ZA024, Durban, KwaZulu-Natal, South Africa ZA007, Thabazimbi, Limpopo, South Africa ZA022, Madibeng, North-West, South Africa ZA013, Cape Town, Western Cape, South Africa ZA014, Worcester, Western Cape, South Africa |
| 2190 | Completed | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom | COVID-19 | Biological: SARS-CoV-2 rS/Matrix M1-Adjuvant Other: Placebo Biological: Licensed seasonal influenza vaccine |
Phase 3 | Novavax | INDUSTRY | 15138 | All | 18 Years ~ 84 Years | Belfast Health and Social Care Trust (BHSCT) (Site UK011), Belfast, Antrim, United Kingdom Synexus Midlands Clinical Research Centre (Site UK024), Edgbaston, Birmingham, United Kingdom The Royal Cornwall Hospitals NHS Trust (Site UK036), Truro, Cornwall, United Kingdom Royal Devon and Exeter Hospital (Site UK013), Exeter, Devon, United Kingdom "Maidstone Hospital - Central Research and Development Office Above Breast Care Centre - 1st Floor" (Site UK028), Maidstone, Kent, United Kingdom Queen Elizabeth University Hospital (Site UK008), Glasgow, Lanarkshire, United Kingdom Blackpool Teaching Hospitals (Site UK010), Blackpool, Lancashire, United Kingdom Salford Hospital (Site UK030), Oldham, Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre (Site UK026), Waterloo, Liverpool, United Kingdom Royal Free (Site UK012), Hampstead, London, United Kingdom St. George's University Hospitals NHS Foundation Trust Clinical Research Facility (Site UK001), Tooting, London, United Kingdom North Wales Clinical Research Centre (NWCRC) (Site UK027), Wrexham, North Wales, United Kingdom Lakeside Healthcare, Lakeside Surgery (Site UK005), Corby, Northants, United Kingdom Warneford Hospital (Site UK016), Oxford, Oxfordshire, United Kingdom Aberdeen Royal Infirmary (Site UK007), Foresterhill, Aberdeen, United Kingdom Bradford Teaching Hospitals NHS Trust (Site UK018), Bradford, United Kingdom Synexus Wales Clinical Research Centre (Site UK025), Cardiff, United Kingdom Synexus Lancashire Clinical Research Centre (Site UK022), Chorley, United Kingdom Colchester Hospital (Site UK034), Colchester, United Kingdom AES - Glasgow (Site UK033), Glasgow, United Kingdom University Hartlepool Hospital (Site UK021), Hartlepool, United Kingdom Synexus Hexham Clinical Research Centre (Site UK023), Hexham, United Kingdom Royal Lancaster Infirmary (Site UK029), Lancaster, United Kingdom Research & Innovation Centre, St. James's University Hospital (Site UK019), Leeds, United Kingdom St. Thomas' Hospital (Site UK020), London, United Kingdom Chelsea & Westminster NHS Foundation Trust (Site UK006), London, United Kingdom AES - Synexus Manchester (Site UK032), Manchester, United Kingdom Norfolk and Norwich University Hospital NHS Foundation Trust, Norfolk and Norwich University Hospital (Site UK015), Norwich, United Kingdom Wansford and Kingscliffe Practice (Site UK035), Peterborough, United Kingdom AES - Synexus Thames Valley (Site UK031), Reading, United Kingdom University Hospital Southampton NHS Foundation Trust (UHS) (Site UK014), Southampton, United Kingdom Midlands Partnership NHS Foundation Trust Headquarters (Site UK017), Stafford, United Kingdom Stockport NHS Foundation Trust (Site UK009), Stockport, United Kingdom |
